CORNEAL CONSULTANTS OF INDIANA, P.C.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1983-01-01
- Employees
- 11
- Market Cap
- -
- Website
- https://pricevisiongroup.com
Clinical Trials
10
Active:0
Completed:5
Trial Phases
3 Phases
Phase 2:6
Phase 4:1
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials
Phase 2
6 (66.7%)Not Applicable
2 (22.2%)Phase 4
1 (11.1%)Loteprednol Etabonate 0.25% for Prevention of Cornea Transplant Rejection
Phase 4
Completed
- Conditions
- Corneal Endothelial DystrophyCorneal Edema
- Interventions
- First Posted Date
- 2021-11-29
- Last Posted Date
- 2024-08-14
- Lead Sponsor
- Price Vision Group
- Target Recruit Count
- 70
- Registration Number
- NCT05136443
- Locations
- 🇺🇸
Price Vision Group, Indianapolis, Indiana, United States
Corneal Crosslinking for Treatment of Corneal Neovascularization
Phase 2
Recruiting
- Conditions
- Corneal Neovascularization
- First Posted Date
- 2021-03-08
- Last Posted Date
- 2025-07-31
- Lead Sponsor
- Price Vision Group
- Target Recruit Count
- 62
- Registration Number
- NCT04787471
- Locations
- 🇺🇸
Price Vision Group, Indianapolis, Indiana, United States
Effect of Xen Implantation on the Aqueous Humor Proteome
Terminated
- Conditions
- Primary Open Angle Glaucoma
- First Posted Date
- 2019-10-28
- Last Posted Date
- 2022-03-03
- Lead Sponsor
- Price Vision Group
- Target Recruit Count
- 3
- Registration Number
- NCT04141865
- Locations
- 🇺🇸
Price Vision Group, Indianapolis, Indiana, United States
Rhopressa for Corneal Edema Associated With Fuchs Dystrophy
Phase 2
Completed
- Conditions
- Fuchs Endothelial Dystrophy
- Interventions
- Drug: Placebo
- First Posted Date
- 2019-08-09
- Last Posted Date
- 2021-10-19
- Lead Sponsor
- Price Vision Group
- Target Recruit Count
- 29
- Registration Number
- NCT04051463
- Locations
- 🇺🇸
Price Vision Group, Indianapolis, Indiana, United States
Trial of Netarsudil for Acceleration of Corneal Endothelial Restoration
- First Posted Date
- 2019-06-03
- Last Posted Date
- 2023-02-06
- Lead Sponsor
- Price Vision Group
- Target Recruit Count
- 19
- Registration Number
- NCT03971357
- Locations
- 🇺🇸
Price Vision Group, Indianapolis, Indiana, United States
- Prev
- 1
- 2
- Next
News
No news found